(3,3-di-thiophen-2-yl-propyl)-(2-morpholin-4-yl-ethyl)-amine | 938468-47-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (3,3-di-thiophen-2-yl-propyl)-(2-morpholin-4-yl-ethyl)-amine
• 英文别名: N-(2-morpholin-4-ylethyl)-3,3-dithiophen-2-ylpropan-1-amine
• CAS: 938468-47-4
• 化学式: C₁₇H₂₄N₂OS₂
• 分子量: 336.522
• InChiKey: AQQZPEOCAGNBIM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  22
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  81
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  3,3-di-[2]thienyl-acrylic acid ethyl ester 生成 (3,3-di-thiophen-2-yl-propyl)-(2-morpholin-4-yl-ethyl)-amine
  参考文献：
  名称：

  WO2007/60026

  摘要：

  公开号：

文献信息

• Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them
  申请人：Jary Helene

  公开号：US20070179134A1

  公开（公告）日：2007-08-02

  The present invention provides compounds of Formula (I): in which R 1 , R′ 1 , R 2 , R′ 2 , R 3 , and Y have the meanings given in the description are useful in the treatment of conditions susceptible to modulating ion channels, to a process for their preparation, their application by way of medicaments, and to pharmaceutical compositions containing them.

  本发明提供了公式（I）的化合物：其中R1，R′1，R2，R′2，R3和Y具有描述中给出的含义，在调节离子通道易感病症的治疗中有用，以及它们的制备方法，通过药物的方式应用它们，以及包含它们的制药组合物。
• Urea Derivatives Methods For Their Manufacture And Uses Thereof
  申请人：DePrez Pierre

  公开号：US20100240889A1

  公开（公告）日：2010-09-23

  The present invention provides compounds of formula (I): in which R 1 , R′ 1 , R 2 , R′ 2 , R 3 , Y and G have the meanings given in the description, to a process for their preparation, their application by way of medicaments, and to pharmaceutical compositions containing them.

  本发明提供了式（I）的化合物：其中R1，R′1，R2，R′2，R3，Y和G具有描述中给出的含义，以及它们的制备过程，它们通过药物的方式应用，以及含有它们的制药组合物。
• UREA DERIVATIVES, METHODS FOR THEIR MANUFACTURE, AND USES THEREFOR
  申请人：DEPREZ Pierre

  公开号：US20120283255A1

  公开（公告）日：2012-11-08

  The present invention provides compounds of formula (I): in which R 1 , R′ 1 , R 2 , R′ 2 , R 3 , and Y have the meanings given in the description, to a process for their preparation, their application by way of medicaments, and to pharmaceutical compositions containing them.

  本发明提供了公式（I）的化合物：其中R1，R′1，R2，R′2，R3和Y具有描述中给出的含义，以及它们的制备方法，通过药物的方式应用它们，以及包含它们的制药组合物。
• Urea derivatives, methods for their manufacture, and uses thereof
  申请人：Galapagos SAS

  公开号：EP2354137A1

  公开（公告）日：2011-08-10

  The present invention provides compounds of formula (I): in which R1, R'1, R2, R'2, R3, Y and G have the meanings given in the description, to a process for their preparation, their application by way of medicaments, and to pharmaceutical compositions containing them.

  本发明提供了式 (I) 的化合物： 中 R1、R'1、R2、R'2、R3、Y 和 G 的含义，以及它们的制备工艺、它们在药物中的应用和含有它们的药物组合物。
• UREA DERIVATIVES METHODS FOR THEIR MANUFACTURE AND USES THEREOF
  申请人：Proskelia SAS

  公开号：EP1874765A2

  公开（公告）日：2008-01-09